Loading…
First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria
The aim of the study was to assess the frequency and diversity of carbapenemases and extended-spectrum β-lactamases (ESBL) produced by Escherichia coli isolates from patients hospitalised in the Regional Military Hospital of Constantine (Algeria). E. coli isolates were collected over a 2-year period...
Saved in:
Published in: | European journal of clinical microbiology & infectious diseases 2014-09, Vol.33 (9), p.1641-1646 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c511t-3f81974ee189568d5cb3624fd072dc3e918271b7fffa6ef6cb8748ae049664303 |
---|---|
cites | cdi_FETCH-LOGICAL-c511t-3f81974ee189568d5cb3624fd072dc3e918271b7fffa6ef6cb8748ae049664303 |
container_end_page | 1646 |
container_issue | 9 |
container_start_page | 1641 |
container_title | European journal of clinical microbiology & infectious diseases |
container_volume | 33 |
creator | Agabou, A. Pantel, A. Ouchenane, Z. Lezzar, N. Khemissi, S. Satta, D. Sotto, A. Lavigne, J.-P. |
description | The aim of the study was to assess the frequency and diversity of carbapenemases and extended-spectrum β-lactamases (ESBL) produced by
Escherichia coli
isolates from patients hospitalised in the Regional Military Hospital of Constantine (Algeria).
E. coli
isolates were collected over a 2-year period from patients presenting
E. coli
infections. Strains with reduced susceptibility to ertapenem and/or positive for ESBL were characterised with regard to antibiotic resistance,
bla
genes, phylogenetic groups, O25 serotyping, quinolone resistance, repetitive sequence-based polymerase chain reaction (rep-PCR) profiles and multi-locus sequence typing (MLST). Of the 448 isolated
E. coli
, 94 (20.9 %) were multidrug-resistant. One of them (1.1 %) produced a
bla
OXA-48
and was identified as a B1 ST5 strain. The transposon bearing this gene was
Tn
1999.2. This strain was isolated from a patient coming from a border province with Tunisia, where this carbapenemase is endemic. In addition, 84 (18.8 %) isolates among them produced an ESBL with predominance (97.6 %) of
bla
CTX-M-15
, which was coupled with
qnr
genes in 10.9 %. ESBL-producing strains were mainly detected in phylogroups D and A. They displayed 20 rep-PCR profiles and all the clonally related isolates were of the same sequence type (ST). Ten strains (9.4 %) belonged to the pandemic clone ST131. This study describes for the first time the presence of OXA-48-producing
E. coli
and the emergence of the intercontinental ST131
bla
CTX-15
-producing
E. coli
strains in Algeria. |
doi_str_mv | 10.1007/s10096-014-2122-y |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1560136233</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1553104361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-3f81974ee189568d5cb3624fd072dc3e918271b7fffa6ef6cb8748ae049664303</originalsourceid><addsrcrecordid>eNqNkc-KFDEQxoMo7rj6AF4kIIKXaCpJ589xWHZVWNiDK3hrMulkJ0t3Mibdh3mLfWQzzLiKIHhJQtXvq0rVh9BroB-AUvWxttNIQkEQBoyR_RO0AsE7IrjiT9GKGi6IUYyfoRe13tOm0Uo9R2dMKNMUeoUermKpMx58dSXu5pgTzgHffF8Tocmu5GFxMd3hy-q2vkS3jRa7PEZs04Dnrce79vBTdNiNOXn89RY44FDy1DJz9GmueJvrLs52jNUP2M7Y4imOLVD2jykcE16Pd62DfYmeBTtW_-p0n6NvV5e3F5_J9c2nLxfra-I6gJnwoMEo4T1o00k9dG7DJRNhoIoNjnsDminYqBCClT5It9FKaOupMFIKTvk5en-s24b8sfg691Oszo-jTT4vtYdOUmglOf8PtONABZfQ0Ld_ofd5KakNcqBY1xluDhQcKVdyrcWHflfi1BbSA-0PzvZHZ_vmbH9wtt83zZtT5WUz-eFR8cvKBrw7AbY6O4Zik4v1N6cVAMiucezI1ZZKbed_fPGf3X8Cnc66vw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1552559391</pqid></control><display><type>article</type><title>First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria</title><source>Springer Link</source><creator>Agabou, A. ; Pantel, A. ; Ouchenane, Z. ; Lezzar, N. ; Khemissi, S. ; Satta, D. ; Sotto, A. ; Lavigne, J.-P.</creator><creatorcontrib>Agabou, A. ; Pantel, A. ; Ouchenane, Z. ; Lezzar, N. ; Khemissi, S. ; Satta, D. ; Sotto, A. ; Lavigne, J.-P.</creatorcontrib><description>The aim of the study was to assess the frequency and diversity of carbapenemases and extended-spectrum β-lactamases (ESBL) produced by
Escherichia coli
isolates from patients hospitalised in the Regional Military Hospital of Constantine (Algeria).
E. coli
isolates were collected over a 2-year period from patients presenting
E. coli
infections. Strains with reduced susceptibility to ertapenem and/or positive for ESBL were characterised with regard to antibiotic resistance,
bla
genes, phylogenetic groups, O25 serotyping, quinolone resistance, repetitive sequence-based polymerase chain reaction (rep-PCR) profiles and multi-locus sequence typing (MLST). Of the 448 isolated
E. coli
, 94 (20.9 %) were multidrug-resistant. One of them (1.1 %) produced a
bla
OXA-48
and was identified as a B1 ST5 strain. The transposon bearing this gene was
Tn
1999.2. This strain was isolated from a patient coming from a border province with Tunisia, where this carbapenemase is endemic. In addition, 84 (18.8 %) isolates among them produced an ESBL with predominance (97.6 %) of
bla
CTX-M-15
, which was coupled with
qnr
genes in 10.9 %. ESBL-producing strains were mainly detected in phylogroups D and A. They displayed 20 rep-PCR profiles and all the clonally related isolates were of the same sequence type (ST). Ten strains (9.4 %) belonged to the pandemic clone ST131. This study describes for the first time the presence of OXA-48-producing
E. coli
and the emergence of the intercontinental ST131
bla
CTX-15
-producing
E. coli
strains in Algeria.</description><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/s10096-014-2122-y</identifier><identifier>PMID: 24792128</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adolescent ; Adult ; Aged ; Algeria ; Anti-Bacterial Agents - pharmacology ; Antibiotic resistance ; Antibiotics ; Antimicrobial agents ; beta-Lactamases - genetics ; beta-Lactamases - secretion ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Child ; Child, Preschool ; Cloning ; DNA Transposable Elements ; Drug Resistance, Multiple, Bacterial ; E coli ; Enzymes ; Escherichia coli ; Escherichia coli - classification ; Escherichia coli - enzymology ; Escherichia coli - genetics ; Escherichia coli - isolation & purification ; Escherichia coli Infections - microbiology ; Female ; Genes ; Genotype ; Hospitals, Military ; Humans ; Infant ; Infections ; Infectious diseases ; Internal Medicine ; Male ; Medical Microbiology ; Medical sciences ; Microbial Sensitivity Tests ; Middle Aged ; Molecular Typing ; Pandemics ; Patients ; Phylogenetics ; Phylogeny ; Polymerase chain reaction ; Serotyping ; Young Adult</subject><ispartof>European journal of clinical microbiology & infectious diseases, 2014-09, Vol.33 (9), p.1641-1646</ispartof><rights>Springer-Verlag Berlin Heidelberg 2014</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-3f81974ee189568d5cb3624fd072dc3e918271b7fffa6ef6cb8748ae049664303</citedby><cites>FETCH-LOGICAL-c511t-3f81974ee189568d5cb3624fd072dc3e918271b7fffa6ef6cb8748ae049664303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28711165$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24792128$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Agabou, A.</creatorcontrib><creatorcontrib>Pantel, A.</creatorcontrib><creatorcontrib>Ouchenane, Z.</creatorcontrib><creatorcontrib>Lezzar, N.</creatorcontrib><creatorcontrib>Khemissi, S.</creatorcontrib><creatorcontrib>Satta, D.</creatorcontrib><creatorcontrib>Sotto, A.</creatorcontrib><creatorcontrib>Lavigne, J.-P.</creatorcontrib><title>First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria</title><title>European journal of clinical microbiology & infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>The aim of the study was to assess the frequency and diversity of carbapenemases and extended-spectrum β-lactamases (ESBL) produced by
Escherichia coli
isolates from patients hospitalised in the Regional Military Hospital of Constantine (Algeria).
E. coli
isolates were collected over a 2-year period from patients presenting
E. coli
infections. Strains with reduced susceptibility to ertapenem and/or positive for ESBL were characterised with regard to antibiotic resistance,
bla
genes, phylogenetic groups, O25 serotyping, quinolone resistance, repetitive sequence-based polymerase chain reaction (rep-PCR) profiles and multi-locus sequence typing (MLST). Of the 448 isolated
E. coli
, 94 (20.9 %) were multidrug-resistant. One of them (1.1 %) produced a
bla
OXA-48
and was identified as a B1 ST5 strain. The transposon bearing this gene was
Tn
1999.2. This strain was isolated from a patient coming from a border province with Tunisia, where this carbapenemase is endemic. In addition, 84 (18.8 %) isolates among them produced an ESBL with predominance (97.6 %) of
bla
CTX-M-15
, which was coupled with
qnr
genes in 10.9 %. ESBL-producing strains were mainly detected in phylogroups D and A. They displayed 20 rep-PCR profiles and all the clonally related isolates were of the same sequence type (ST). Ten strains (9.4 %) belonged to the pandemic clone ST131. This study describes for the first time the presence of OXA-48-producing
E. coli
and the emergence of the intercontinental ST131
bla
CTX-15
-producing
E. coli
strains in Algeria.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Algeria</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>beta-Lactamases - genetics</subject><subject>beta-Lactamases - secretion</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cloning</subject><subject>DNA Transposable Elements</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>E coli</subject><subject>Enzymes</subject><subject>Escherichia coli</subject><subject>Escherichia coli - classification</subject><subject>Escherichia coli - enzymology</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli - isolation & purification</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Female</subject><subject>Genes</subject><subject>Genotype</subject><subject>Hospitals, Military</subject><subject>Humans</subject><subject>Infant</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medical Microbiology</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Middle Aged</subject><subject>Molecular Typing</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Phylogenetics</subject><subject>Phylogeny</subject><subject>Polymerase chain reaction</subject><subject>Serotyping</subject><subject>Young Adult</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqNkc-KFDEQxoMo7rj6AF4kIIKXaCpJ589xWHZVWNiDK3hrMulkJ0t3Mibdh3mLfWQzzLiKIHhJQtXvq0rVh9BroB-AUvWxttNIQkEQBoyR_RO0AsE7IrjiT9GKGi6IUYyfoRe13tOm0Uo9R2dMKNMUeoUermKpMx58dSXu5pgTzgHffF8Tocmu5GFxMd3hy-q2vkS3jRa7PEZs04Dnrce79vBTdNiNOXn89RY44FDy1DJz9GmueJvrLs52jNUP2M7Y4imOLVD2jykcE16Pd62DfYmeBTtW_-p0n6NvV5e3F5_J9c2nLxfra-I6gJnwoMEo4T1o00k9dG7DJRNhoIoNjnsDminYqBCClT5It9FKaOupMFIKTvk5en-s24b8sfg691Oszo-jTT4vtYdOUmglOf8PtONABZfQ0Ld_ofd5KakNcqBY1xluDhQcKVdyrcWHflfi1BbSA-0PzvZHZ_vmbH9wtt83zZtT5WUz-eFR8cvKBrw7AbY6O4Zik4v1N6cVAMiucezI1ZZKbed_fPGf3X8Cnc66vw</recordid><startdate>20140901</startdate><enddate>20140901</enddate><creator>Agabou, A.</creator><creator>Pantel, A.</creator><creator>Ouchenane, Z.</creator><creator>Lezzar, N.</creator><creator>Khemissi, S.</creator><creator>Satta, D.</creator><creator>Sotto, A.</creator><creator>Lavigne, J.-P.</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>7T2</scope><scope>7U2</scope></search><sort><creationdate>20140901</creationdate><title>First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria</title><author>Agabou, A. ; Pantel, A. ; Ouchenane, Z. ; Lezzar, N. ; Khemissi, S. ; Satta, D. ; Sotto, A. ; Lavigne, J.-P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-3f81974ee189568d5cb3624fd072dc3e918271b7fffa6ef6cb8748ae049664303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Algeria</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>beta-Lactamases - genetics</topic><topic>beta-Lactamases - secretion</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cloning</topic><topic>DNA Transposable Elements</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>E coli</topic><topic>Enzymes</topic><topic>Escherichia coli</topic><topic>Escherichia coli - classification</topic><topic>Escherichia coli - enzymology</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli - isolation & purification</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Female</topic><topic>Genes</topic><topic>Genotype</topic><topic>Hospitals, Military</topic><topic>Humans</topic><topic>Infant</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medical Microbiology</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Middle Aged</topic><topic>Molecular Typing</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Phylogenetics</topic><topic>Phylogeny</topic><topic>Polymerase chain reaction</topic><topic>Serotyping</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Agabou, A.</creatorcontrib><creatorcontrib>Pantel, A.</creatorcontrib><creatorcontrib>Ouchenane, Z.</creatorcontrib><creatorcontrib>Lezzar, N.</creatorcontrib><creatorcontrib>Khemissi, S.</creatorcontrib><creatorcontrib>Satta, D.</creatorcontrib><creatorcontrib>Sotto, A.</creatorcontrib><creatorcontrib>Lavigne, J.-P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><jtitle>European journal of clinical microbiology & infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Agabou, A.</au><au>Pantel, A.</au><au>Ouchenane, Z.</au><au>Lezzar, N.</au><au>Khemissi, S.</au><au>Satta, D.</au><au>Sotto, A.</au><au>Lavigne, J.-P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria</atitle><jtitle>European journal of clinical microbiology & infectious diseases</jtitle><stitle>Eur J Clin Microbiol Infect Dis</stitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>2014-09-01</date><risdate>2014</risdate><volume>33</volume><issue>9</issue><spage>1641</spage><epage>1646</epage><pages>1641-1646</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><abstract>The aim of the study was to assess the frequency and diversity of carbapenemases and extended-spectrum β-lactamases (ESBL) produced by
Escherichia coli
isolates from patients hospitalised in the Regional Military Hospital of Constantine (Algeria).
E. coli
isolates were collected over a 2-year period from patients presenting
E. coli
infections. Strains with reduced susceptibility to ertapenem and/or positive for ESBL were characterised with regard to antibiotic resistance,
bla
genes, phylogenetic groups, O25 serotyping, quinolone resistance, repetitive sequence-based polymerase chain reaction (rep-PCR) profiles and multi-locus sequence typing (MLST). Of the 448 isolated
E. coli
, 94 (20.9 %) were multidrug-resistant. One of them (1.1 %) produced a
bla
OXA-48
and was identified as a B1 ST5 strain. The transposon bearing this gene was
Tn
1999.2. This strain was isolated from a patient coming from a border province with Tunisia, where this carbapenemase is endemic. In addition, 84 (18.8 %) isolates among them produced an ESBL with predominance (97.6 %) of
bla
CTX-M-15
, which was coupled with
qnr
genes in 10.9 %. ESBL-producing strains were mainly detected in phylogroups D and A. They displayed 20 rep-PCR profiles and all the clonally related isolates were of the same sequence type (ST). Ten strains (9.4 %) belonged to the pandemic clone ST131. This study describes for the first time the presence of OXA-48-producing
E. coli
and the emergence of the intercontinental ST131
bla
CTX-15
-producing
E. coli
strains in Algeria.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>24792128</pmid><doi>10.1007/s10096-014-2122-y</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0934-9723 |
ispartof | European journal of clinical microbiology & infectious diseases, 2014-09, Vol.33 (9), p.1641-1646 |
issn | 0934-9723 1435-4373 |
language | eng |
recordid | cdi_proquest_miscellaneous_1560136233 |
source | Springer Link |
subjects | Adolescent Adult Aged Algeria Anti-Bacterial Agents - pharmacology Antibiotic resistance Antibiotics Antimicrobial agents beta-Lactamases - genetics beta-Lactamases - secretion Biological and medical sciences Biomedical and Life Sciences Biomedicine Child Child, Preschool Cloning DNA Transposable Elements Drug Resistance, Multiple, Bacterial E coli Enzymes Escherichia coli Escherichia coli - classification Escherichia coli - enzymology Escherichia coli - genetics Escherichia coli - isolation & purification Escherichia coli Infections - microbiology Female Genes Genotype Hospitals, Military Humans Infant Infections Infectious diseases Internal Medicine Male Medical Microbiology Medical sciences Microbial Sensitivity Tests Middle Aged Molecular Typing Pandemics Patients Phylogenetics Phylogeny Polymerase chain reaction Serotyping Young Adult |
title | First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A30%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=First%20description%20of%20OXA-48-producing%20Escherichia%20coli%20and%20the%20pandemic%20clone%20ST131%20from%20patients%20hospitalised%20at%20a%20military%20hospital%20in%20Algeria&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=Agabou,%20A.&rft.date=2014-09-01&rft.volume=33&rft.issue=9&rft.spage=1641&rft.epage=1646&rft.pages=1641-1646&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/s10096-014-2122-y&rft_dat=%3Cproquest_cross%3E1553104361%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c511t-3f81974ee189568d5cb3624fd072dc3e918271b7fffa6ef6cb8748ae049664303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1552559391&rft_id=info:pmid/24792128&rfr_iscdi=true |